Join John Rose at 100% Optical: Discover the Valeda Treatment for Dry AMD

By adminjohnrose | February 22, 2025 |

If you’re attending 100% Optical, don’t miss the chance to learn from John Rose, the first optometrist in the world to offer the revolutionary Valeda Light Delivery System—the only FDA-approved photobiomodulation treatment for dry age-related macular degeneration (AMD). Age-Related Macular Degeneration is a Leading Cause of Blindness in Adults Over 65. What is the Valeda Light Delivery System? Valeda is a…

Read More

Discover the Latest in Dry AMD Treatment with John Rose Optometrist

By adminjohnrose | November 27, 2024 |

​ Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda. 🎧✨ Listen to the…

Read More

The Valeda LDS treatment for dry AMD is now FDA approved

By adminjohnrose | November 9, 2024 |

LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…

Read More